Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortMulti-kinase capsule for kidney cancer and GIST.Multi-kinase tablet for liver, kidney and thyroid cancers.
Body systemCancerCancer
Drug classTyrosine kinase inhibitorsTyrosine kinase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription only
Main usesAdvanced kidney cancer, Gastrointestinal stromal tumour (GIST), Pancreatic neuroendocrine tumoursHepatocellular (liver) cancer, Advanced kidney cancer, Differentiated thyroid cancer
How it worksSlows tumour growth and blood supply.Slows tumour growth and blood supply.
Starts workingDepends on the cancer and regimenDepends on the cancer and regimen
Half-life40–60 hours (sunitinib); 80–110 hours (metabolite)25–48 hours
Typical adult doseDosed by your cancer team according to the treatment protocol.Dosed by your cancer team according to the treatment protocol.
FormsCapsuleTablet
Common side effectsTiredness, Diarrhoea, High blood pressure, Mouth sores, Yellowing of skin, Hand-foot syndromeHand-foot skin reaction, Diarrhoea, High blood pressure, Rash, Tiredness
Serious side effectsHeart failure, Liver failure, Underactive thyroid, BleedingBleeding, Heart problems, Liver injury, Bowel perforation
Don't take ifPregnancy; Uncontrolled high blood pressure; Severe liver impairmentPregnancy; Uncontrolled high blood pressure
AlcoholBest to limit. Alcohol may add to liver strain.Best to limit. Alcohol may add to liver strain.
PregnancyUsually avoidedAvoid.Usually avoidedAvoid.
BreastfeedingUsually avoidedAvoid.Usually avoidedAvoid.
In use since——
Brand namesUnited States: SutentUnited Kingdom: SutentIndia: Sutent, Sunitinib (generic), SutinibUnited States: NexavarUnited Kingdom: NexavarIndia: Nexavar, Sorafenib (generic), Soranib
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL01EX01—

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker